Literature DB >> 33903635

Testicular steroidogenesis is suppressed during experimental autoimmune encephalomyelitis in rats.

Ana Milosevic1, Ivana Bjelobaba1, Iva D Bozic1, Irena Lavrnja1, Danijela Savic1, Katarina Tesovic1, Marija Jakovljevic1, Stanko S Stojilkovic2, Marija M Janjic3.   

Abstract

Multiple sclerosis (MS) is an autoimmune disease that usually occurs during the reproductive years in both sexes. Many male patients with MS show lower blood testosterone levels, which was also observed in male rats during experimental autoimmune encephalomyelitis (EAE), an animal model of MS. To better understand the causes of decreased testosterone production during EAE, we investigated the expression status of genes and proteins associated with steroidogenesis in the testes. No changes in the number of interstitial cells were observed in EAE animals, but the expression of the insulin-like 3 gene was reduced at the peak of the disease, implying that the Leydig cell functional capacity was affected. Consistent with this finding, the expression of most steroidogenic enzyme genes and proteins was reduced during EAE, including StAR, CYP11A1, CYP17A1 and HSD3B. No signs of testicular inflammation were observed. Recovery of steroidogenesis was observed after injection of hCG, the placental gonadotropin, or buserelin acetate, a gonadotropin-releasing hormone analogue, at the peak of EAE. Together, our results are consistent with the hypothesis that impaired testicular steroidogenesis originates upstream of the testes and that low serum LH is the main cause of decreased testosterone levels during EAE.

Entities:  

Year:  2021        PMID: 33903635     DOI: 10.1038/s41598-021-88305-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

1.  A gender gap in autoimmunity.

Authors:  C C Whitacre; S C Reingold; P A O'Looney
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

2.  The sex-specific patterns of changes in hypothalamic-pituitary-gonadal axis during experimental autoimmune encephalomyelitis.

Authors:  Ana Milosevic; Marija M Janjic; Irena Lavrnja; Danijela Savic; Iva D Bozic; Katarina Tesovic; Marija Jakovljevic; Sanja Pekovic; Stanko S Stojilkovic; Ivana Bjelobaba
Journal:  Brain Behav Immun       Date:  2020-06-24       Impact factor: 7.217

Review 3.  Gonadotropin receptors and regulation of steroidogenesis in the testis and ovary.

Authors:  M L Dufau; K J Catt
Journal:  Vitam Horm       Date:  1978       Impact factor: 3.421

4.  The neuroendocrine axis in patients with multiple sclerosis.

Authors:  T Wei; S L Lightman
Journal:  Brain       Date:  1997-06       Impact factor: 13.501

5.  Sex and gender issues in multiple sclerosis.

Authors:  Hanne F Harbo; Ralf Gold; Mar Tintoré
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

6.  Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Scott C Foster; Crystal Daniels; Dennis N Bourdette; Bruce F Bebo
Journal:  J Neuroimmunol       Date:  2003-07       Impact factor: 3.478

7.  Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis.

Authors:  M R Safarinejad
Journal:  J Neuroendocrinol       Date:  2008-12       Impact factor: 3.627

8.  Serum testosterone and corticosterone levels in acute experimental autoimmune encephalomyelitis (EAE) in male Wistar rats.

Authors:  Daniela R Macció; Gastón Calfa; Marta Volosín; German A Roth
Journal:  Neuro Endocrinol Lett       Date:  2004-06       Impact factor: 0.765

Review 9.  SR-BI and cholesterol uptake into steroidogenic cells.

Authors:  Margery A Connelly; David L Williams
Journal:  Trends Endocrinol Metab       Date:  2003-12       Impact factor: 12.015

Review 10.  Current knowledge on the acute regulation of steroidogenesis.

Authors:  Vimal Selvaraj; Douglas M Stocco; Barbara J Clark
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.